- Home
- BRKR vs CELH Comparison
BRKR vs CELH Comparison
Compare BRKR & CELH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRKR
- CELH
- Stock Information
- Founded
- BRKR 1991
- CELH 2004
- Country
- BRKR United States
- CELH United States
- Employees
- BRKR N/A
- CELH N/A
- Industry
- BRKR Biotechnology: Laboratory Analytical Instruments
- CELH Beverages (Production/Distribution)
- Sector
- BRKR Industrials
- CELH Consumer Staples
- Exchange
- BRKR Nasdaq
- CELH Nasdaq
- Market Cap
- BRKR 9.2B
- CELH 6.8B
- IPO Year
- BRKR 2000
- CELH N/A
- Fundamental
- Price
- BRKR $61.26
- CELH $26.87
- Analyst Decision
- BRKR Buy
- CELH Strong Buy
- Analyst Count
- BRKR 13
- CELH 18
- Target Price
- BRKR $75.67
- CELH $50.22
- AVG Volume (30 Days)
- BRKR 1.4M
- CELH 7.2M
- Earning Date
- BRKR 02-11-2025
- CELH 02-27-2025
- Dividend Yield
- BRKR 0.33%
- CELH N/A
- EPS Growth
- BRKR N/A
- CELH 47.74
- EPS
- BRKR 2.06
- CELH 0.72
- Revenue
- BRKR $3,241,300,000.00
- CELH $1,370,868,000.00
- Revenue This Year
- BRKR $15.23
- CELH $5.39
- Revenue Next Year
- BRKR $7.52
- CELH $15.69
- P/E Ratio
- BRKR $30.54
- CELH $37.37
- Revenue Growth
- BRKR 15.00
- CELH 19.36
- 52 Week Low
- BRKR $48.07
- CELH $25.23
- 52 Week High
- BRKR $94.86
- CELH $99.62
- Technical
- Relative Strength Index (RSI)
- BRKR 58.41
- CELH 43.85
- Support Level
- BRKR $58.78
- CELH $26.08
- Resistance Level
- BRKR $64.64
- CELH $30.27
- Average True Range (ATR)
- BRKR 1.98
- CELH 1.35
- MACD
- BRKR 0.39
- CELH -0.01
- Stochastic Oscillator
- BRKR 59.23
- CELH 26.57
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from Asia Pacific.
About CELH Celsius Holdings Inc.
Celsius Holdings plays in the energy drink subsegment of the global nonalcoholic beverage market, with 96% of revenue concentrated in North America. Celsius' products contain natural ingredients and a metabolism-enhancing formulation, appealing to fitness and active lifestyle enthusiasts. The firm's portfolio includes its namesake Celsius Originals beverages, Celsius Essentials line (containing aminos), and Celsius On-the-Go powder packets. Celsius dedicates its efforts to branding and innovation, while it utilizes third parties for the manufacturing, packaging, and distribution of its products. In 2022, Celsius forged a 20-year distribution agreement with PepsiCo, which holds an 8.5% stake in the business.